HealthMyne announced today that it has raised a $15 million Series B round to expand its global commercialization efforts.

According to a release, Ascension Ventures led the round, which also saw Venture Investors, 4490 Ventures, and WARF participate.

“There is exceptional interest in the market for an integrated platform that can solve multiple high-impact problems in the diagnosis and treatment of patients across the healthcare enterprise,” HealthMyne President & CEO Arvind Subramanian said in a statement. “Ascension Ventures’ investment is great validation that community health systems are looking for ways to get more clinical yield out of their imaging and (clinical decision support) investments and partnerships.”

Ascension Ventures was launched in 2001 by Ascension, the nation’s largest Catholic and non-profit health system. It has more than $800 million in capital under management.

HealthMyne delivers Quantitative Imaging Decision Support for radiology and oncology departments in U.S.-based multi-hospital systems.